Ibrutinib’s Success in CLL Treatment: Supported by Real World Data
Final results are in from the EVIdeNCE study, which analyzed 309 chronic lymphocytic leukemia (CLL) patients [...]
EU Probes China’s Medical Device Market Access
The European Commission has initiated an investigation into China's public procurement practices for medical devices, increasing [...]
Implications for Medical Affairs Teams in 2024 and Beyond
In 2024, medical affairs teams are pivotal in driving strategic impact within the pharmaceutical industry. They [...]
Aerial Contagion: Redefining Airborne Pathogens
The World Health Organization (WHO) has recently announced a revision of its classification of airborne pathogens, [...]
Bridging Urban-Rural Healthcare Gaps Through Real-World Data
Medical research and clinical trials have historically favored urban communities, resulting in an underrepresentation of rural [...]
Chiesi Focuses on Patient-Centered Care in Fabry Disease
Chiesi Global Rare Diseases has published survey results in the Orphanet Journal of Rare Diseases that [...]
ISPOR 2024: Keynote Speakers and Sessions Announced
The ISPOR 2024 conference, a key event for Health Economics and Outcomes Research (HEOR), will take [...]
Forecast of the Global Real World Evidence (RWE) Solutions Market
The Global Real World Evidence (RWE) Solutions Market is forecasted to grow from 2.7 billion (USD) [...]
Bristol Myers Squibb Expands Partnership with Cellares in $380 Million Deal
Bristol Myers Squibb (BMS) has reinforced its collaboration with Cellares by signing a $380 million agreement, [...]
Entyvio: New Subcutaneous Option for Crohn’s Disease Patients
Takeda's Entyvio, a medication for Crohn's disease, has been approved for a subcutaneous (SC) formulation. Originally [...]
Urgent Transparency Needed in H5N1 Bird Flu Outbreaks Affecting U.S. Dairy Cattle
As H5N1 bird flu spreads across U.S. dairy cattle herds, significant concerns have arisen regarding the [...]
Addressing Challenges in Pharmaceutical Innovation through Strategic Collaboration and Digital Transformation
The pharmaceutical industry faces critical challenges, including focusing on profit-driven blockbuster drugs at the expense of [...]
Abbott’s Q1 2024 Earnings: Strong Medical Device Sales Lead to Raised Financial Forecasts
Abbott Laboratories experienced a robust first quarter in 2024, driven primarily by its medical devices segment. [...]
Expansion and Enhancement of Telehealth and Teletherapy Services Post-Pandemic
The pandemic significantly highlighted the benefits of telehealth, making remote medical consultations a preferred choice for [...]
Biden Administration Launches Global Health Security Strategy to Combat Infectious Diseases
The Biden administration has unveiled a comprehensive plan to strengthen global health security by assisting 50 [...]
Study Reveals Racial Disparities in Prostate Cancer Care
A landmark study conducted by Analysis Group has highlighted significant racial disparities in the treatment and [...]
Regeneron Launches $500M Venture Investment Arm
Regeneron Pharmaceuticals is venturing into the investment domain, allocating up to $500 million for its new [...]
FDA Proposes Eliminating Biosimilars’ Interchangeability Designation
The FDA is advocating for the removal of the "interchangeability" label for biosimilars to simplify the [...]
House Committee Grills FDA Commissioner on Drug Shortages and Inspections
FDA Commissioner Robert Califf faced intense questioning from the House Committee on Oversight and Accountability regarding [...]
European Regulators Find No Link Between GLP-1 Drugs and Suicidal Ideation
European Medicines Agency (EMA) investigations have concluded that GLP-1 class drugs, like Ozempic and Wegovy, used [...]
Advantages of Early Minimally Invasive Surgery for Intracerebral Hemorrhage
Abstract: Recent trials examining the efficacy of surgical evacuation for supratentorial intracerebral hemorrhages have predominantly indicated [...]
Economic Paradox: Resilient Growth Amid Persistent Inflation
The economy defies expectations with its sustained growth despite high-interest rates that traditionally dampen economic activity. [...]
Vertex Pharmaceuticals Acquires Alpine Immune Sciences for $4.9 Billion
Vertex Pharmaceuticals is set to acquire Alpine Immune Sciences for $4.9 billion, expanding its portfolio into [...]
Mtech Access are exhibiting at ISPOR in the US
Atlanta, GA, USA, May 5-8 2024: Mtech Access are delighted to announce that they will be [...]
Sanofi to Close Kiadis Division Amid Pipeline Prioritization
Sanofi has decided to shut down Kiadis, a natural killer (NK) cell company acquired for $357 [...]
